Linlin Lv
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Ubiquitin and proteasome pathways 5
- Cancer-related gene regulation 4
- Oncology 7
- Pancreatic and Hepatic Oncology Research 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Deshi Dong (11 shared papers)Xiaohan Zhai (7 shared papers)Huijian Wu (8 shared papers)Xufeng Tao (5 shared papers)Lingli Zheng (1 shared paper)Yan Qi (1 shared paper)Lina Xu (1 shared paper)Xu Han (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Cell Death Discovery (2 papers)RSC Advances (2 papers)Cell Death and Disease (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- China
In The Last Decade
Linlin Lv
28 papers receiving 426 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 73
- Oncology 93
- Molecular Biology 234
- Biological Psychiatry 8
- Complementary and alternative medicine 25
Countries citing papers authored by Linlin Lv
This map shows the geographic impact of Linlin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlin Lv more than expected).
Fields of papers citing papers by Linlin Lv
This network shows the impact of papers produced by Linlin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlin Lv. The network helps show where Linlin Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Linlin Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 100 | |
| 2 | 2022 | 42 | |
| 3 | 2023 | 42 | |
| 4 | 2023 | 37 | |
| 5 | 2022 | 25 | |
| 6 | 2021 | 20 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 17 | |
| 9 | 2022 | 16 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2013 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2009 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2023 | 5 |
About Linlin Lv
Linlin Lv is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Organic Chemistry, having authored 30 papers that have together received 433 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer-related gene regulation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Quinazolinone synthesis and applications (2 papers), Pancreatitis Pathology and Treatment (2 papers), Cancer-related Molecular Pathways (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (73 citations), Oncology (93 citations), Molecular Biology (234 citations), Biological Psychiatry (8 citations) and Complementary and alternative medicine (25 citations). Linlin Lv has collaborated with scholars based in China. Frequent co-authors include Deshi Dong, Xiaohan Zhai, Huijian Wu, Xufeng Tao, Lingli Zheng, Yan Qi, Lina Xu, Xu Han, Lianhong Yin and Jinyong Peng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cell Death Discovery, RSC Advances, Cell Death and Disease and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.